EP0771186A1 - Detergent composition - Google Patents
Detergent compositionInfo
- Publication number
- EP0771186A1 EP0771186A1 EP95925905A EP95925905A EP0771186A1 EP 0771186 A1 EP0771186 A1 EP 0771186A1 EP 95925905 A EP95925905 A EP 95925905A EP 95925905 A EP95925905 A EP 95925905A EP 0771186 A1 EP0771186 A1 EP 0771186A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- benefit agent
- surface active
- mixtures
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Definitions
- the present invention relates to detergent compositions suitable for the care and personal washing of the skin.
- compositions which are formulated to give mild cleansing and conditioning of the skin.
- compositions formulated to cleanse the skin are well known. It is also known to formulate products which provide both a cleansing and a moisturising benefit.
- WO 90/13283 discloses a composition comprising an acyl ester of an isethionic acid salt, a long chain fatty acid, a moisturiser component and, optionally, soap.
- compositions such that they can deliver effective moisturising, conditioning or protection of the skin.
- the maximum average droplet size of the silicone oil that can be used is 2 microns, if product stability is to be maintained.
- particle by particle is meant a solid particle or liquid droplet, of benefit agents such as silicone oil can be incorporated into non-soap based compositions and stable compositions formed by the use of structurants .
- an aqueous liquid cleansing and moisturising composition comprising:-
- a surface active agent selected from anionic, non-Lome, zwitterionic, and cationic surface active agents; and mixtures thereof;
- composition is substantially free of insoluble fatty acid soap and has a viscosity of at least 5,000 Pas at a shear stress of 0.01 Pa at 25°C.
- the viscosity quoted is the minimum viscosity required to suspend benefit agent having a weight average particle size of 50 microns such that the composition has a separation rate at 25°C of less than 1mm per year.
- the composition is suitable for cleansing and "moisturising", “conditioning” or “protection” of the skin.
- the benefit agent is included in the composition to moisturise, condition and/or protect the skin.
- “benefit agent” is meant a substance that softens the skin (stratum corneum) and keeps it soft by retarding the decrease of its water content or protects the skin.
- Preferred benefit agents include a) silicone oils, gums and modifications thereof such as linear and cyclic polydimethylsiloxanes; amino, alkyl alkylaryl and aryl silicone oils; b) fats and oils including natural fats and oils such as jojoba, soyabean, rice bran, avocado, almond, olive, sesame, persic, castor, coconut, mink oils; cacao fat, beef tallow, lard; hardened oils obtained by hydrogenating the aforementioned oils; and synthetic mono, di and triglycerides such as myristic acid glyceride and 2-ethylhexanoic acid glyceride; c) waxes such as carnauba, spermaceti, beeswax, lanolin and derivatives thereof; d) hydrophobic plant extracts; e) hydrocarbons such as liquid paraffins, petrolatum, microcrystalline wax, ceresin, squalene, squalane, and mineral oil;
- sunscreens such as octyl methoxyl cinnamate (Parsol MCX) and butyl methoxy benzoylmethane (Parsol 1789); m) Phospholipids; and n) mixtures of any of the foregoing components.
- the benefit agent may be incorporated in a carrier in the compositions of the invention, particularly if it is likely to suffer detrimental interactions with other components of the composition.
- Benefit agents for which such detrimental interactions may occur include lipids; alkyl lactates; sunscreens; esters such as isopropyl palmitate and isopropyl yriscate; and vitamins.
- the carrier can, for example, be a silicone or hydrocarbon oil which is not solubilised/ micellised by the surface active phase and in which the benefit agent is relatively soluble.
- Particularly preferred benefit agents include silicone oils, gums and modifications thereof; esters such as isopropyl palmitate and myristate and alkyl lactates.
- the benefit agent is preferably present in amount of from 0.1 to 15 wt%, most preferably from 0.2 to 10 wt%, more preferably from 0.5 to 7 wt%.
- composition according to the invention deposits benefit agent onto the skin at a level which results in a perceivable benefit.
- benefit agent is dispersed into large pools during dilution of the composition in use and these pools deposit readily onto the skin.
- compositions comprising large particles of petrolatum are structured by the presence of at least 5wt% insoluble fatty acid soap.
- insoluble fatty acid soap by which is meant the level of insoluble fatty acid soap is below 1 wt% based on the composition.
- Suitable structurants are those materials which when added to a composition, will increase the zero shear rate viscosity. They include swelling clays, for example laponite; fatty acid and derivatives thereof, in particular fatty acid monoglyceride polyglycol ether; cross-linked polyacrylates such as Carbopol (TM) (polymers available from Goodrich); acrylates and copolymers thereof; polyvinylpyrrolidone and copolymers thereof; polyethylene i ines; salts such as sodium chloride and ammonium sulphate; sucrose esters; gellants; and mixtures thereof.
- swelling clays for example laponite
- fatty acid and derivatives thereof in particular fatty acid monoglyceride polyglycol ether
- cross-linked polyacrylates such as Carbopol (TM) (polymers available from Goodrich); acrylates and copolymers thereof; polyvinylpyrrolidone and copolymers thereof; polyethylene i ines; salts such as sodium chloride
- clays particularly preferred are synthetic hectorite (laponite) clay used in conjunction with an electrolyte salt capable of causing the clay to thicken so as to suspend the benefit agent.
- electrolytes include alkali and alkaline earth salts such as halides, ammonium salts and sulphates.
- Particularly preferred structurants include fatty acids and derivatives thereof and cross-linked polyacrylates.
- composition comprises two or more benefit agents one of said benefit agents may also function as a structurant.
- compositions according to the invention may also comprise a thickening agent, i.e. a material which maintains the viscosity of the composition as the shear rate thereof is increased during use.
- a thickening agent i.e. a material which maintains the viscosity of the composition as the shear rate thereof is increased during use.
- Suitable materials include cross- linked polyacrylates such as Carbopol (TM) (polymers available from Goodrich); fatty acid and derivatives thereof, in particular, fatty acid monoglyceride polyglycol ether; natural gums including alginates, guar, xanthan and polysaccharide derivatives including carboxy methyl cellulose and hydroxypropyl guar; propylene glycols and propylene glycol oleates; salts such as sodium chloride and ammonium sulphate; glycerol tallowates; and mixtures thereof.
- Further examples of structurants and thickeners are given n the International Cosmetic Ingredient Dictionary, Fifth Edition
- the surface active agent can be selected from any known surfactant suitable for topical application to the human body. Mild surfactants, i.e. surfactants which do not damage the stratum corneum, the outer layer of the skin, are particularly preferred.
- One preferred anionic detergent is fatty acyl isethionate of formula:
- R is an alkyl or alkenyl group of 7 to 21 carbon atoms and M is a solubilising cation such as sodium, potassium, ammonium or substituted ammonium.
- M is a solubilising cation such as sodium, potassium, ammonium or substituted ammonium.
- RCO groups Preferably at least three quarters of the RCO groups have 12 to 18 carbon atoms and may be derived from coconut, palm or coconut/palm blends.
- alkyl ether sulphate of formula:
- R is an alkyl group of 8 to 22 carbon atoms
- n ranges from 0.5 to 10, especially from 1.5 to 8
- M is a solubilising cation as defined above.
- anionic detergents include alkyl glyceryl ether sulphate, sulphosuccmates, taurates, sarcosinates, sulphoacetates, alkyl phosphate, alkyl phosphate esters and acyl lactates, alkyl glutamates and mixtures thereof.
- Sulphoauccmates may be monoalkyl sulphosuccmates having the formula: R 5 0 2 CCH,CH(SO : M)CO ; M; and amido-MEA sulphosuccmates of the formula: R 5 CONHCH 2 CH 2 0 2 CCH 2 CH(SO,M)C0 2 M; wherein R 5 ranges from C 3 -C 20 alkyl, preferably C l2 -C lit alkyl, and M is a solubilising cation.
- Sarcosinates are generally indicated by the formula: R 5 C0N(CH 3 )CH 2 C0 2 M, wherein R 5 ranges from C ⁇ -C 20 alkyl, preferably C 12 -C 15 alkyl and M is a solubilising cation.
- Taurates are generally identified by the formula: R 5 C0NR 6 CH,CH 2 S0 3 M, wherein R 5 ranges from C 9 -C 20 alkyl, preferably C 12 -C 15 alkyl, R 6 ranges from C,-C 4 alkyl, and M is a solubilising cation.
- Harsh surfactants such as primary alkane sulphonate or alkyl benzene sulphonate will generally be avoided.
- Suitable nonionic surface active agents include alkyl polysaccharides, lactobiona ides, ethyleneglycol esters, glycerol monoethers, polyhydroxyamides (glucamide) , primary and secondary alcohol ethoxylates, especially the C B . 20 aliphatic alcohols ethoxylated with an average of from 1 to 20 moles of ethylene oxide per mole of alcohol.
- the surface active agent is preferably present at a level of from 1 to 35 wt%, preferably 3 to 30 wt%.
- the composition includes from 0.5 to 15 wt% of a cosurfactant with skin-mildness benefits.
- Suitable materials are zwitte ⁇ onic detergents which have an alkyl or alkenyl group of 7 to 18 carbon atoms and comply with an overall structural formula R 1 - [ -C-NH ( CH, ) n - ] n -N * - X-Y I
- R 1 is alkyl or alkenyl of 7 to 18 carbon atoms
- R 2 and R 3 are each independently alkyl, hydroxyalkyl or carboxyalkyl of 1 to 3 carbon atoms
- m is 2 to 4
- n is 0 or 1;
- X is alkylene of 1 to 3 carbon atoms optionally substituted with hydroxyl
- Y is -C0 2 " or -S0 3 "
- Zwitterionic detergents within the above general formula include simple betaines of formula:-
- R 1 , R 2 and R 3 are as defined previously.
- R 1 may, in particular, be a mixture of C 12 and C 14 alkyl groups derived from coconut so that at least half, preferably at least three quarters, of the group R 1 has 10 to 14 carbon atoms.
- R 2 and R 3 are preferably methyl.
- a further possibility is a sulphobetaine of formula:-
- R 1 , R 2 and R 3 in these formulae are as defined previously.
- the benefit agent may also function as a carrier to deliver efficacy agents to skin treated with the compositions of the invention.
- This route is particularly useful for delivering efficacy agents which are difficult to deposit onto the skin or those which suffer detrimental interactions with other components in the composition.
- the carrier is a often a silicone or hydrocarbon oil which is not solubilised/micellised by the surface active phase and in which the efficacy agent is relatively soluble.
- efficacy agents include anti-viral agents; hydroxycaprylic acids; pyrrolidone; carboxylic acids; 2,4,4 ' -trichloro-2 ' -hydroxydiphenyl ether (Irgasan DP300); 3 , 4, 4 ' -trichlorocarbanilide; salicylic acid; benzoyl peroxide; perfumes; essential oils; germicides and insect repellants such as N,N-dimethyl m-toluamide (DEET) ; and mixtures thereof.
- anti-viral agents include anti-viral agents; hydroxycaprylic acids; pyrrolidone; carboxylic acids; 2,4,4 ' -trichloro-2 ' -hydroxydiphenyl ether (Irgasan DP300); 3 , 4, 4 ' -trichlorocarbanilide; salicylic acid; benzoyl peroxide; perfumes; essential oils; germicides and insect repellants such as N,N-dimethyl
- compositions of the invention may be formulated as products for washing the skin, for example bath or shower gels, hand washing compositions, facial .washing liquids; pre-and post- shaving products; rinse-off, wipe-off and leave-on skin care products.
- compositions of the invention will generally be pourable liquids or semi-liquids for example pastes and will preferably have a viscosity in the range 1000 to 100,000 mPas measured at a shear rate of 10s "1 at 25°C in a Haake Rotoviscometer RV20.
- compositions will exhibit a Newtonian viscosity at a shear stress of 0.01 Pa at 25°C of at least 5,000 Pas preferably greater than 10,000 Pas.
- characteristic viscosity measurements may be determined exactly (as in the case of the non-zero shear viscosites) using, for example, a Carrimed CSL 100 low stress rheometer, or obtained from an extrapolation according to the Cross Model (see J of the Chemical Engineer, 1993, paper entitled “Rheology for the Chemical Engineer” by H Barnes) as in the case of the zero shear rate.
- compositions include opaci- fiers, preferably 0.2 to 2.0 wt%; preservatives, preferably 0.2 to 2.0 wt% and perfumes, preferably 0.5 to 2.0 wt%.
- compositions according to the invention comprising:- a) structuring the base formulation comprising at least one surface active agent selected from anionic, nonionic, zwitterionic, and cationic surface active agents, and mixtures thereof with a structurant; and
- Alkylpolyglucoside was Plantaren 2000 ex Henkel Coco amidopropyl betaine was Amonyl BA 380 ex Seppic.
- Cross-linked polyacrylate was Carbopol ETD 2020 ex Goodrich.
- Fatty acid monoglyceride polyglycol ether was Rewoderm L1580 ex Rewo.
- Guar hydroxypropyl trimonium chloride was Jaguar C-13-S ex Meyhali.
- Silicone oil emulsion was BC 92/057 ex Basildon.
- Silicone oil was DC200, a polydimethylsiloxane ex Dow Corning with a viscosity of 60000 mPas.
- the following method was used to determine the amount of benefit agent deposited onto full thickness porcine skin (5 x 15 cm) treated with compositions according to the invention.
- the skin was prehydrated and then 0.5 ml of the product applied to it.
- the product was lathered for 10 seconds and then rinsed for 10 seconds under running water.
- a strip of adhesive tape was pressed onto the skin for 30 seconds by applying a constant load of lOOg.cm "2 .
- the adhesive tape employed was J-Lar Superclear (TM) tape having a width of 2.5cm. In total ten strips of tape were applied to adjacent sites on the skin.
- the amounts of silicon and skin adhering to the tape are determined by means of X-ray fluorescence spectroscopy.
- the tape strips are placed in an X-ray fluorescence spectrometer with the adhesive side facing the beam of this machine.
- a mask is applied over the tape to define a standardised area in the middle of the tape which is exposed to the X-ray beam.
- the sample chamber of the machine is placed under vacuum before making measurements and the spectrometer is then used to measure the quantities of silicon and sulphur.
- the sulphur is representative of the amount of skin which has transferred to the tape.
- composition A deposition of silicon from a composition comprising a silicone oil with a weight average size of 80 microns was determined and compared with that from a similar composition (composition A) comprising a silicone oil emulsion having a weight average size of 0.5 micron.
- a base shower gel formulation having the following composition was prepared.
- This level can be varied to obtain a pH for the composition of 5.3.
- the viscosity of the composition was 5500 mPas at 10s "1 and 25°C.
- the base formulation was prepared by mixing sodium lauryl ether sulphate and betaine. Thereafter the remaining components were added with mixing.
- Silicone oil was present at a level of 5 wt% based on the total composition.
- One syringe was filled with the base formu- lation and the other with silicone oil.
- the syringes were then inserted into the syringe pump and the infusion rate set at 5:95 oil:base.
- the oil and base were forced through a static in-line mixer and a composition with oil particles of the required size obtained.
- the size of the particles can be controlled by the diameter of the static mixer, the flow rate and length of the mixer tube. The size of the particles can be determined using a Malvern Mastersizer.
- # level can be varied in order to give the required viscosity of 5000 mPas at 10s" 1 and 25°C.
- the benefit agent used was silicone oil with a viscosity of 60000 mPas.
- the composition was prepared by dispersing the polyacrylate in excess water. Thereafter sorbic acid and trisodium citrate dihydrate were added to the resulting polymer dispersion. The three surface active agents were mixed and the resulting mix added to the polymer dispersion. Thereafter minors were added. The viscosity of the resulting composition was measured at a shear rate of 10s "1 at 25°C and thickener added until the required viscosity obtained. The base formulation and silicone oil were infused using two Harvard 44 syringe pumps as described above. The viscosity of the final product was 5500 mPas.
- compositions comprising a number of different sized oil particles were prepared. Silicone deposition from these compositions was measured by the test procedure described above and compared with that from composition (A) .
- the products were stored in a sealed glass vessel at 37°C. After 6 weeks they were still stable, i.e. there was no visible separation.
- composition in this example the stability of a composition according to the invention structured with a cross-linked polyacrylate was compared with an identical composition from which the structurant was absent.
- the composition comprised
- the benefit agent used was silicone oil present in an amount of 5wt%.
- the viscosity of the product according to the invention and of the comparison were, respectively, 4628 and 5500 mPas at 10s "1 and 25°C and 22783 and 12.16 mPas at 0.01 Pa and 25°C.
- compositions were stored in sealed glass vessels and placed in a oven at 37°C.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
An aqueous liquid cleansing and moisturising composition comprisign a surface active agent, a skin benefit agent having a weight average particle size in the range 50 to 500 microns and a structurant. The composition is substantially free of insoluble fatty acid soap and has a viscosity of at least 5000 Pas at a shear stress of 0.01 Pa at 25 °C.
Description
DETERGENT COMPOST TQN
The present invention relates to detergent compositions suitable for the care and personal washing of the skin. In particular, it relates to compositions which are formulated to give mild cleansing and conditioning of the skin.
Compositions formulated to cleanse the skin are well known. It is also known to formulate products which provide both a cleansing and a moisturising benefit.
For example WO 90/13283 discloses a composition comprising an acyl ester of an isethionic acid salt, a long chain fatty acid, a moisturiser component and, optionally, soap.
One of the problems which may be encountered with such dual purpose compositions is that, whilst cleansing may be effective, there is an insufficient level of moisturising.
We have found a way of formulating such compositions such that they can deliver effective moisturising, conditioning or protection of the skin.
In WO 94/01085 and 94/01084 the advantage of depositing large particles of petrolatum from soap based compositions to moisturise the skin is recognised.
However, according to WO 94/03152, concerned with shower gels comprising a non-soap detergent, silicone oil added to condition the skin and cationic polymers, the maximum average droplet size of the silicone oil that can be used is 2 microns, if product stability is to be maintained.
We have now found that larger particles, by particle is meant a solid particle or liquid droplet, of benefit agents such as
silicone oil can be incorporated into non-soap based compositions and stable compositions formed by the use of structurants .
Thus, according to the invention there is provided an aqueous liquid cleansing and moisturising composition comprising:-
a) a surface active agent selected from anionic, non-Lome, zwitterionic, and cationic surface active agents; and mixtures thereof;
b) a benefit agent having a weight average particle size in the range 50 to 500 microns; and
c) at least one structurant;
wherein the composition is substantially free of insoluble fatty acid soap and has a viscosity of at least 5,000 Pas at a shear stress of 0.01 Pa at 25°C.
The viscosity quoted is the minimum viscosity required to suspend benefit agent having a weight average particle size of 50 microns such that the composition has a separation rate at 25°C of less than 1mm per year.
As the weight average particle size of the benefit agent increases much higher viscosities are required to give a composition with the same stability.
The composition is suitable for cleansing and "moisturising", "conditioning" or "protection" of the skin. The benefit agent is included in the composition to moisturise, condition
and/or protect the skin. By "benefit agent" is meant a substance that softens the skin (stratum corneum) and keeps it soft by retarding the decrease of its water content or protects the skin.
Preferred benefit agents include a) silicone oils, gums and modifications thereof such as linear and cyclic polydimethylsiloxanes; amino, alkyl alkylaryl and aryl silicone oils; b) fats and oils including natural fats and oils such as jojoba, soyabean, rice bran, avocado, almond, olive, sesame, persic, castor, coconut, mink oils; cacao fat, beef tallow, lard; hardened oils obtained by hydrogenating the aforementioned oils; and synthetic mono, di and triglycerides such as myristic acid glyceride and 2-ethylhexanoic acid glyceride; c) waxes such as carnauba, spermaceti, beeswax, lanolin and derivatives thereof; d) hydrophobic plant extracts; e) hydrocarbons such as liquid paraffins, petrolatum, microcrystalline wax, ceresin, squalene, squalane, and mineral oil; f) higher fatty acids such as lauric, myristic, palmitic, stearic, behenic, oleic, linoleic linolenic, lanolic, isostearic and poly unsaturated fatty acids (PUFA) acids; g) higher alcohols such as lauryl, cetyl, steryl, oleyl, behenyl, cholesterol and 2-hexadecanol alcohol; h) esters such as cetyl octanoate, myristyl lactate, cetyl lactate, isopropyl myristate, myristyl myristate, isopropyl palmitate, isopropyl adipate, butyl stearate, decyl oleate, cholesterol isostearate, glycerol monostearate, glycerol
iistearate, glycerol tristearate, alkyl lactate for example lauryl lactate, alkyl citrate and alkyl tartrate; i) essential oils such as fish oils, entha, jasmine, camphor, white cedar, bitter orange peel, ryu, turpentine, cinnamon, bergamont, citrus unshiu, calamus, pine, lavender, bay, clove, hiba, eucalyptus, lemon, starflower, thyme, peppermint, rose, sage, menthol, cineole, eugenol, citral, citronelle, borneol, linalool, geraniol, evening primrose, camphor, thymol, spirantol, pinene, limonene and terpenoid oils; j) lipids such as cholesterol, ceramides, sucrose esters and pseudo-ceramides as described in European Patent Specification No. 556 957; k) vitamins such as vitamin A and E, and vitamin alkyl esters, including those vitamin C alkyl esters;
1) sunscreens such as octyl methoxyl cinnamate (Parsol MCX) and butyl methoxy benzoylmethane (Parsol 1789); m) Phospholipids; and n) mixtures of any of the foregoing components.
The benefit agent may be incorporated in a carrier in the compositions of the invention, particularly if it is likely to suffer detrimental interactions with other components of the composition. Benefit agents for which such detrimental interactions may occur include lipids; alkyl lactates; sunscreens; esters such as isopropyl palmitate and isopropyl yriscate; and vitamins. The carrier can, for example, be a silicone or hydrocarbon oil which is not solubilised/ micellised by the surface active phase and in which the benefit agent is relatively soluble.
Particularly preferred benefit agents include silicone oils, gums and modifications thereof; esters such as isopropyl palmitate and myristate and alkyl lactates.
The benefit agent is preferably present in amount of from 0.1 to 15 wt%, most preferably from 0.2 to 10 wt%, more preferably from 0.5 to 7 wt%.
An advantage of the composition according to the invention is that, during use, it deposits benefit agent onto the skin at a level which results in a perceivable benefit. Without being bound by theory, it is believed the benefit agent is dispersed into large pools during dilution of the composition in use and these pools deposit readily onto the skin.
In WO 94/01084 and WO 94/01085 compositions comprising large particles of petrolatum are structured by the presence of at least 5wt% insoluble fatty acid soap. However, it is believed such high levels of solid phase material may adversely affect the amount of benefit agent deposited onto the skin. Thus, in the present invention we require the composition to be substantially free of insoluble fatty acid soap, by which is meant the level of insoluble fatty acid soap is below 1 wt% based on the composition.
Structurants are an essential feature of the present invention. Suitable structurants are those materials which when added to a composition, will increase the zero shear rate viscosity. They include swelling clays, for example laponite; fatty acid and derivatives thereof, in particular fatty acid monoglyceride polyglycol ether; cross-linked polyacrylates such as Carbopol (TM) (polymers available from Goodrich); acrylates and copolymers thereof;
polyvinylpyrrolidone and copolymers thereof; polyethylene i ines; salts such as sodium chloride and ammonium sulphate; sucrose esters; gellants; and mixtures thereof.
Of the clays particularly preferred are synthetic hectorite (laponite) clay used in conjunction with an electrolyte salt capable of causing the clay to thicken so as to suspend the benefit agent. Suitable electrolytes include alkali and alkaline earth salts such as halides, ammonium salts and sulphates.
Particularly preferred structurants include fatty acids and derivatives thereof and cross-linked polyacrylates.
Whilst some materials can function as both a benefit agent and structurant it will be appreciated that the benefit and structuring function cannot be provided by the same component. However, it will be understood that where the composition comprises two or more benefit agents one of said benefit agents may also function as a structurant.
The compositions according to the invention may also comprise a thickening agent, i.e. a material which maintains the viscosity of the composition as the shear rate thereof is increased during use. Suitable materials include cross- linked polyacrylates such as Carbopol (TM) (polymers available from Goodrich); fatty acid and derivatives thereof, in particular, fatty acid monoglyceride polyglycol ether; natural gums including alginates, guar, xanthan and polysaccharide derivatives including carboxy methyl cellulose and hydroxypropyl guar; propylene glycols and propylene glycol oleates; salts such as sodium chloride and ammonium sulphate; glycerol tallowates; and mixtures thereof.
Further examples of structurants and thickeners are given n the International Cosmetic Ingredient Dictionary, Fifth Edition, 1993, published by CTFA (The Cosmetic, Toiletry & Fragrance Association) , incorporated herein by reference.
The surface active agent can be selected from any known surfactant suitable for topical application to the human body. Mild surfactants, i.e. surfactants which do not damage the stratum corneum, the outer layer of the skin, are particularly preferred.
One preferred anionic detergent is fatty acyl isethionate of formula:
RCO,CH,CH2S03M
where R is an alkyl or alkenyl group of 7 to 21 carbon atoms and M is a solubilising cation such as sodium, potassium, ammonium or substituted ammonium. Preferably at least three quarters of the RCO groups have 12 to 18 carbon atoms and may be derived from coconut, palm or coconut/palm blends.
Another preferred anionic detergent is alkyl ether sulphate of formula:
RO(CH2CH-0)-,S03M
where R is an alkyl group of 8 to 22 carbon atoms, n ranges from 0.5 to 10, especially from 1.5 to 8, and
M is a solubilising cation as defined above.
Other possible anionic detergents include alkyl glyceryl ether sulphate, sulphosuccmates, taurates, sarcosinates, sulphoacetates, alkyl phosphate, alkyl phosphate esters and acyl lactates, alkyl glutamates and mixtures thereof.
Sulphoauccmates may be monoalkyl sulphosuccmates having the formula: R502CCH,CH(SO:M)CO;M; and amido-MEA sulphosuccmates of the formula: R5CONHCH2CH202CCH2CH(SO,M)C02M; wherein R5 ranges from C3-C20 alkyl, preferably Cl2-Clit alkyl, and M is a solubilising cation.
Sarcosinates are generally indicated by the formula: R5C0N(CH3)CH2C02M, wherein R5 ranges from Cβ-C20 alkyl, preferably C12-C15 alkyl and M is a solubilising cation.
Taurates are generally identified by the formula: R5C0NR6CH,CH2S03M, wherein R5 ranges from C9-C20 alkyl, preferably C12-C15 alkyl, R6 ranges from C,-C4 alkyl, and M is a solubilising cation.
Harsh surfactants such as primary alkane sulphonate or alkyl benzene sulphonate will generally be avoided.
Suitable nonionic surface active agents include alkyl polysaccharides, lactobiona ides, ethyleneglycol esters, glycerol monoethers, polyhydroxyamides (glucamide) , primary and secondary alcohol ethoxylates, especially the CB.20 aliphatic alcohols ethoxylated with an average of from 1 to 20 moles of ethylene oxide per mole of alcohol.
The surface active agent is preferably present at a level of from 1 to 35 wt%, preferably 3 to 30 wt%.
It is also preferable that the composition includes from 0.5 to 15 wt% of a cosurfactant with skin-mildness benefits. Suitable materials are zwitteπonic detergents which have an alkyl or alkenyl group of 7 to 18 carbon atoms and comply with an overall structural formula
R1 - [ -C-NH ( CH, ) n- ] n-N*- X-Y I
R3
where R1 is alkyl or alkenyl of 7 to 18 carbon atoms; R2 and R3 are each independently alkyl, hydroxyalkyl or carboxyalkyl of 1 to 3 carbon atoms; m is 2 to 4; n is 0 or 1;
X is alkylene of 1 to 3 carbon atoms optionally substituted with hydroxyl; and
Y is -C02 " or -S03 "
Zwitterionic detergents within the above general formula include simple betaines of formula:-
and amido betaines of formula:-
R1 - CONH(CH2)m-N*-CH2C02
RJ where m is 2 or 3.
In both formulae R1, R2 and R3 are as defined previously.
R1 may, in particular, be a mixture of C12 and C14 alkyl groups derived from coconut so that at least half, preferably at
least three quarters, of the group R1 has 10 to 14 carbon atoms. R2 and R3 are preferably methyl.
A further possibility is a sulphobetaine of formula:-
R2
I R1-^- (CH,)3S03
I R3 or R2
I
R'-CONHtCHj),. N*- (CH,)3S03 R3 where m is 2 or 3, or variants of these in which -(CH,)3S03 ~ is replaced by
OH
I -CH,CHCH2S03
R1, R2 and R3 in these formulae are as defined previously.
Furthermore, the benefit agent may also function as a carrier to deliver efficacy agents to skin treated with the compositions of the invention. This route is particularly useful for delivering efficacy agents which are difficult to deposit onto the skin or those which suffer detrimental interactions with other components in the composition. In such cases the carrier is a often a silicone or hydrocarbon oil which is not solubilised/micellised by the surface active phase and in which the efficacy agent is relatively soluble. Examples of such efficacy agents include anti-viral agents; hydroxycaprylic acids; pyrrolidone; carboxylic acids; 2,4,4 ' -trichloro-2 ' -hydroxydiphenyl ether (Irgasan DP300); 3 , 4, 4 ' -trichlorocarbanilide; salicylic acid; benzoyl
peroxide; perfumes; essential oils; germicides and insect repellants such as N,N-dimethyl m-toluamide (DEET) ; and mixtures thereof.
Compositions of the invention may be formulated as products for washing the skin, for example bath or shower gels, hand washing compositions, facial .washing liquids; pre-and post- shaving products; rinse-off, wipe-off and leave-on skin care products.
The compositions of the invention will generally be pourable liquids or semi-liquids for example pastes and will preferably have a viscosity in the range 1000 to 100,000 mPas measured at a shear rate of 10s"1 at 25°C in a Haake Rotoviscometer RV20.
The compositions will exhibit a Newtonian viscosity at a shear stress of 0.01 Pa at 25°C of at least 5,000 Pas preferably greater than 10,000 Pas.
The above-mentioned characteristic viscosity measurements may be determined exactly (as in the case of the non-zero shear viscosites) using, for example, a Carrimed CSL 100 low stress rheometer, or obtained from an extrapolation according to the Cross Model (see J of the Chemical Engineer, 1993, paper entitled "Rheology for the Chemical Engineer" by H Barnes) as in the case of the zero shear rate.
Other typical components of the compositions include opaci- fiers, preferably 0.2 to 2.0 wt%; preservatives, preferably 0.2 to 2.0 wt% and perfumes, preferably 0.5 to 2.0 wt%.
According to a further aspect of the invention there is provided a process for preparing compositions according to the invention comprising:-
a) structuring the base formulation comprising at least one surface active agent selected from anionic, nonionic, zwitterionic, and cationic surface active agents, and mixtures thereof with a structurant; and
b) mixing the structured base formulation with the benefit agent.
The invention will be further illustrated by reference to the following non-limiting examples.
Examples
In the examples: -
Alkylpolyglucoside was Plantaren 2000 ex Henkel Coco amidopropyl betaine was Amonyl BA 380 ex Seppic.
Cross-linked polyacrylate was Carbopol ETD 2020 ex Goodrich.
Fatty acid monoglyceride polyglycol ether was Rewoderm L1580 ex Rewo.
Guar hydroxypropyl trimonium chloride was Jaguar C-13-S ex Meyhali.
Silicone oil emulsion was BC 92/057 ex Basildon.
Silicone oil was DC200, a polydimethylsiloxane ex Dow Corning with a viscosity of 60000 mPas.
Sodium lauryl ether sulphate was Genapol ZRO ex Hoechst Thickener was Antil 141 (a propylene glycol and propylene glycol oleate) ex Goldschmidt
πχr.mplfls i-ii
The following method was used to determine the amount of benefit agent deposited onto full thickness porcine skin (5 x 15 cm) treated with compositions according to the invention.
The skin was prehydrated and then 0.5 ml of the product applied to it. The product was lathered for 10 seconds and then rinsed for 10 seconds under running water.
Thereafter the skin was wiped once with a paper towel to remove excess water.
2 minutes after drying a strip of adhesive tape was pressed onto the skin for 30 seconds by applying a constant load of lOOg.cm"2. The adhesive tape employed was J-Lar Superclear (TM) tape having a width of 2.5cm. In total ten strips of tape were applied to adjacent sites on the skin.
In this test procedure silicone which has deposited on the skin will subsequently be transferred to the tape along with some of the outer layer of the skin.
The amounts of silicon and skin adhering to the tape are determined by means of X-ray fluorescence spectroscopy. The tape strips are placed in an X-ray fluorescence spectrometer with the adhesive side facing the beam of this machine. A mask is applied over the tape to define a standardised area in the middle of the tape which is exposed to the X-ray beam. The sample chamber of the machine is placed under vacuum before making measurements and the spectrometer is then used to measure the quantities of silicon and sulphur. The sulphur is representative of the amount of skin which has transferred to the tape.
The amounts of silicon and sulphur observed with a clean piece of adhesive tape are subtracted from the experimental measurements. The experimental measurements for the average levels of sulphur and silicon are expressed as a ratio of silicon to sulphur. From this ratio it is possible to determine silicone oil deposition per unit area of skin.
Example I
In this example deposition of silicon from a composition comprising a silicone oil with a weight average size of 80 microns was determined and compared with that from a similar composition (composition A) comprising a silicone oil emulsion having a weight average size of 0.5 micron.
A base shower gel formulation having the following composition was prepared.
% by weight Sodium lauryl ether sulphate 13.0
Coco a idopropyl betaine 2.0 Sorbic acid 0.37
Sodium citrate dihydrate 0.49
Fatty acid monoglyceride polyglycol ether 3.00 Citric acid -0.01"
Water + minors to 100
* This level can be varied to obtain a pH for the composition of 5.3.
The viscosity of the composition was 5500 mPas at 10s"1 and 25°C.
The base formulation was prepared by mixing sodium lauryl ether sulphate and betaine. Thereafter the remaining components were added with mixing.
Two Harvard 44 syringe pumps were used to infuse the base formulation and the benefit agent, silicone oil. Silicone oil was present at a level of 5 wt% based on the total composition. One syringe was filled with the base formu- lation and the other with silicone oil. The syringes were
then inserted into the syringe pump and the infusion rate set at 5:95 oil:base. The oil and base were forced through a static in-line mixer and a composition with oil particles of the required size obtained. The size of the particles can be controlled by the diameter of the static mixer, the flow rate and length of the mixer tube. The size of the particles can be determined using a Malvern Mastersizer.
Comparative Composition f omposition A) wt
Sodium lauryl ether sulphate 13.00
Coco amidopropyl betaine (CAPB) 2.00
Silicone oil emulsion 5.00
Guar hydroxypropyl trimonium 0.10 chloride
Sorbic acid 0.37
Sodium citrate dihydrate 0.49
Sodium chloride* 2
Citric acid* 0.01 Water + minors to 100
# level can be varied in order to give the required viscosity of 5000 mPas at 10s"1 and 25°C.
* level can be varied in order to give the required pH.
Silicone deposition of these compositions were measured by the test procedure described above and the following results obtained. Si:S
Example I 25.6
Comparison (A) 2.2
The results demonstrate the improved deposition achieved when the composition comprises large particle size silicone oil.
A base shower gel formulation having the following composition was prepared.
Sodium lauryl ether sulphate 4.00
Sodium coco a ido propyl betaine 1.00 Alkylpolyglucoside 5.00
Sorbic acid 0.37
Trisodium citrate dihydrate 0.49
Cross-linked polyacrylate 0.9
Thickener** -1 5N NaOH*** -1
Water + minors to 100
** Thickener was added to give the required viscosity (-5000 mPas at 10s"1 and 25°C)
*** 5N NaOH was added to adjust the pH of the composition to pH 5.3.
The benefit agent used was silicone oil with a viscosity of 60000 mPas.
The composition was prepared by dispersing the polyacrylate in excess water. Thereafter sorbic acid and trisodium citrate dihydrate were added to the resulting polymer dispersion. The three surface active agents were mixed and the resulting mix added to the polymer dispersion. Thereafter minors were added. The viscosity of the resulting composition was measured at a shear rate of 10s"1 at 25°C and thickener added until the required viscosity obtained.
The base formulation and silicone oil were infused using two Harvard 44 syringe pumps as described above. The viscosity of the final product was 5500 mPas.
Compositions comprising a number of different sized oil particles were prepared. Silicone deposition from these compositions was measured by the test procedure described above and compared with that from composition (A) .
The following results were obtained:-
Particle size Gf. Si :S ratio silicone oil
0.5 0.8
24 1.4
52 3.7
88 8.3
130 16.8
138 18.1
The results demonstrate the benefit of using large particle size benefit agent.
The products were stored in a sealed glass vessel at 37°C. After 6 weeks they were still stable, i.e. there was no visible separation.
Example II
In this example the stability of a composition according to the invention structured with a cross-linked polyacrylate was compared with an identical composition from which the structurant was absent.
The composition comprised
Sodium lauryl ether sulphate 4.00
Sodium coco a ido propyl betaine 1.00 Alkylpolyglucoside 5.00
Sorbic acid 0.37
Trisodium citrate dihydrate 0.49
Cross-linked polyacrylate 0.9#
Thickener 0.97 Water + minors to 100
5N NaOH was added to adjust the pH of the composition to pH 5.3.
# absent from the comparative formulation.
The benefit agent used was silicone oil present in an amount of 5wt%.
The viscosity of the product according to the invention and of the comparison were, respectively, 4628 and 5500 mPas at 10s"1 and 25°C and 22783 and 12.16 mPas at 0.01 Pa and 25°C.
Both compositions were stored in sealed glass vessels and placed in a oven at 37°C.
Whereas the comparative composition separated after three days the composition according to the invention was still stable after 4 weeks.
Claims
1. An aqueous liquid cleansing and moisturising composition comprising:-
a) a surface active agent selected from anionic, nonionic, zwitterionic, and cationic surface active agents, and mixtures thereof;
b) a benefit agent having a weight average particle size in the range 50 to 500 microns; and
c) at least one structurant;
wherein the composition is substantially free of insoluble fatty acid soap and has a viscosity of at least 5,000 Pas at a shear stress of 0.01 Pa at 25°C.
2. A composition according to claim 1 wherein the structurant is selcted from swelling clays; fatty acid and derivatives thereof; cross-linked polyacrylates; acrylates and copolymers thereof; polyvinylpyrrolidone and copolymers thereof; polyethylene imines; salts; sucrose esters; gellants; and mixtures thereof.
3. A composition according to claim 1 wherein the benefit agent is selected from silicone oils; gums; fats; oils; waxes; hydrophobic plant extracts; hydrocarbons; higher fatty acids; higher fatty alcohols; esters; essential oils; lipids; phospholipids; vitamins; sunscreens; and mixtures thereof.
4. A composition according to any one of the preceding claims comprising 0.1 to 15 wt% of the benefit agent.
5. A composition according to any one of the preceding claims wherein the benefit agent functions as a carrier to deliver efficacy agents to skin treated with the composition.
6. A composition according to any one of the preceding claims comprising 1 to 35 wt% of the surface active agent.
7. A process for preparing a composition according to claim 1 comprises:-
a) structuring the base formulation comprising at least one surface active agent selected from anionic, nonionic, zwitterionic and cationic surface active agents and mixtures thereof; and
b) mixing the structured base formulation with the benefit agent.
8. A method of depositing a benefit agent from an aqueous liquid cleansing and moisturising composition, the method comprising providing the benefit agent in a composition comprising
a) a surface active agent selected from anionic, nonionic, zwitterionic, and cationic surface active agents, and mixtures thereof;
b) the benefit agent having a weight average particle size in the range 50 to 500 microns; and
c) at least one structurant;
the composition being substantially free of insoluble fatty acid soap and having a viscosity of at least 5,000 Pas at a shear stress of 0.01 Pa at 25°C.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9414575 | 1994-07-19 | ||
GB9414575A GB9414575D0 (en) | 1994-07-19 | 1994-07-19 | Detergent composition |
PCT/GB1995/001687 WO1996002224A1 (en) | 1994-07-19 | 1995-07-18 | Detergent composition |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0771186A1 true EP0771186A1 (en) | 1997-05-07 |
Family
ID=10758574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95925905A Withdrawn EP0771186A1 (en) | 1994-07-19 | 1995-07-18 | Detergent composition |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0771186A1 (en) |
JP (1) | JPH09512824A (en) |
KR (1) | KR970704418A (en) |
AU (1) | AU2985695A (en) |
BR (1) | BR9508782A (en) |
CA (1) | CA2190739A1 (en) |
GB (1) | GB9414575D0 (en) |
WO (1) | WO1996002224A1 (en) |
ZA (1) | ZA955973B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2154809T3 (en) * | 1995-03-29 | 2001-04-16 | Unilever Nv | LIQUID CLEANING COMPOSITIONS. |
ES2177948T3 (en) * | 1996-03-14 | 2002-12-16 | Johnson & Johnson Consumer | COMPOSITIONS OF CLEANSING AND MOISTURIZING TENSIOACTIVE. |
US6066608A (en) * | 1996-09-23 | 2000-05-23 | The Procter & Gamble Company | Liquid personal cleansing composition which contain a lipophilic skin moisturing agent comprised of relatively large droplets |
US5854293A (en) * | 1996-09-23 | 1998-12-29 | The Procter & Gamble Company | Liquid personal cleansing composition which contain a lipophilic skin moisturizing agent comprised of relatively large droplets |
US5804540A (en) * | 1997-01-08 | 1998-09-08 | Lever Brothers Company, Division Of Conopco, Inc. | Personal wash liquid composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
GB9704643D0 (en) | 1997-03-06 | 1997-04-23 | Johnson & Johnson | Chemical composition |
EP0937495A3 (en) * | 1998-02-23 | 2002-07-10 | Unilever Plc | Mixing immiscible liquids |
US6423329B1 (en) | 1999-02-12 | 2002-07-23 | The Procter & Gamble Company | Skin sanitizing compositions |
US6183766B1 (en) | 1999-02-12 | 2001-02-06 | The Procter & Gamble Company | Skin sanitizing compositions |
US6395691B1 (en) * | 2001-02-28 | 2002-05-28 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Personal wash compositions containing particle-in-oil dispersion |
US6395690B1 (en) * | 2001-02-28 | 2002-05-28 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Process for making mild moisturizing liquids containing large oil droplet |
IL162227A0 (en) | 2001-12-21 | 2005-11-20 | Rhodia | Stable surfactant compositions for suspending components |
US8092787B2 (en) * | 2003-05-22 | 2012-01-10 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced effect of optical modifier separate from structured benefit agent |
US7875582B2 (en) * | 2003-05-22 | 2011-01-25 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Nonbar personal product compositions comprising crystalline wax structured benefit agent premix or delivery vehicle |
EP1967173A1 (en) | 2007-03-06 | 2008-09-10 | Peter Greven Hautschutz GmbH & Co. KG | Skin cleaning agent with particles comprising hardened castor oil |
BRPI0809314A2 (en) | 2007-03-23 | 2014-10-14 | Rhodia | STRUCTURED SURFACE COMPOSITIONS |
US8772212B2 (en) | 2008-08-07 | 2014-07-08 | Conopco, Inc. | Liquid personal cleansing composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63130512A (en) * | 1986-11-18 | 1988-06-02 | Toray Silicone Co Ltd | Cosmetic |
ATE118165T1 (en) * | 1989-06-21 | 1995-02-15 | Colgate Palmolive Co | HAIR-NOURISHING SHAMPOO. |
FR2660554B1 (en) * | 1990-04-05 | 1992-07-03 | Oreal | AQUEOUS COSMETIC OR DERMO-PHARMACEUTICAL COMPOSITION CONTAINING SUSPENSION HYDRATED SPHEROUIDES OF A HYDROPHILIC LIPID SUBSTANCE. |
GB9024162D0 (en) * | 1990-11-07 | 1990-12-19 | Unilever Plc | Detergent composition |
AU3136593A (en) * | 1991-11-22 | 1993-06-15 | Richardson-Vicks Inc. | Combined personal cleansing and moisturizing compositions |
GB9200764D0 (en) * | 1992-01-15 | 1992-03-11 | Unilever Plc | Cosmetic composition |
AU3811193A (en) * | 1992-03-25 | 1993-10-21 | Procter & Gamble Company, The | Cleansing compositions |
GB9207799D0 (en) * | 1992-04-09 | 1992-05-27 | Procter & Gamble | Aqueous compositions |
US5308526A (en) * | 1992-07-07 | 1994-05-03 | The Procter & Gamble Company | Liquid personal cleanser with moisturizer |
GB9301295D0 (en) * | 1993-01-23 | 1993-03-17 | Procter & Gamble | Cleansing compositions |
-
1994
- 1994-07-19 GB GB9414575A patent/GB9414575D0/en active Pending
-
1995
- 1995-07-18 CA CA002190739A patent/CA2190739A1/en not_active Abandoned
- 1995-07-18 BR BR9508782A patent/BR9508782A/en not_active Application Discontinuation
- 1995-07-18 KR KR1019970700339A patent/KR970704418A/en not_active Application Discontinuation
- 1995-07-18 EP EP95925905A patent/EP0771186A1/en not_active Withdrawn
- 1995-07-18 ZA ZA955973A patent/ZA955973B/en unknown
- 1995-07-18 JP JP8504828A patent/JPH09512824A/en active Pending
- 1995-07-18 WO PCT/GB1995/001687 patent/WO1996002224A1/en not_active Application Discontinuation
- 1995-07-18 AU AU29856/95A patent/AU2985695A/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO9602224A1 * |
Also Published As
Publication number | Publication date |
---|---|
JPH09512824A (en) | 1997-12-22 |
AU2985695A (en) | 1996-02-16 |
KR970704418A (en) | 1997-09-06 |
WO1996002224A1 (en) | 1996-02-01 |
ZA955973B (en) | 1997-01-20 |
CA2190739A1 (en) | 1996-02-01 |
BR9508782A (en) | 1997-11-25 |
GB9414575D0 (en) | 1994-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5661189A (en) | Detergent composition | |
EP0771188B1 (en) | Soap composition | |
EP0755243B1 (en) | Detergent composition | |
CA2354772C (en) | Aqueous cleansing and moisturising composition comprising aggregated particles | |
US5929019A (en) | Cleansing composition with separately dispensed cleansing base and benefit base wherein benefit base also comprises surfactant | |
US5912002A (en) | Cleansing composition comprising surfactant and internal emulsion comprising cosmetic agent, emulsifier and carrier | |
EP0771186A1 (en) | Detergent composition | |
MXPA01006118A (en) | Detergent composition | |
MXPA99006517A (en) | Cleansing composition with separately dispensed cleansing base and benefit base wherein benefit base also comprises surfactant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19961111 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE ES FR GB IT |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20000201 |